Skip to main content
SpringerLink
Log in

Benefits outweigh costs of increased CRC screening

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. When fully implemented (expected in 2020) the NBCSP will invite people aged 50−74 years to complete a faecal occult blood test every 2 years. Currently, the programme is limited to those aged 50, 55, 60, 64, 65, 70, 72 and 74 years.

  2. Australasian Colorectal Cancer Family Registry

  3. National Health and Medical Research Council

Reference

  • Dillon M, et al. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios. PLOS Medicine : 16 Aug 2018. Available from: URL: https://doi.org/10.1371/journal.pmed.1002630

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benefits outweigh costs of increased CRC screening. PharmacoEcon Outcomes News 811, 4 (2018). https://doi.org/10.1007/s40274-018-5233-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5233-3

Search

Navigation